Dr. Scott is a Clinical Lecturer in Pharmacology and Infectious Disease at the University of Liverpool. Her main research interests are optimizing the doses of therapeutics using pharmacokinetic and pharmacodynamic models in particular anti-Ebola and anti-Schistosome therapeutics. She trained in Parasitology at the University of Glasgow and holds a PhD in the cellular immuno-epidemiology of Schistosomiasis also from the University of Glasgow with research in The Gambia and Zimbabwe. Between 1997 and 2002 she continued her interest in the schistosome immunology in the North of Senegal, based in the Institute of Tropical Medicine, Antwerp. In 2002 she moved to Oxford to read Medicine. In 2006 she joined the Jenner Institute, Oxford to study a Tuberculosis candidate vaccine and prepare trial sites in Kenya for an HIV vaccine study. During the Ebola 2014-16 epidemic she was the clinical lead for the Brincidofovir Trial (Monrovia, Liberia), and Convalescent Plasma (Freetown, Sierra Leone) and is currently the Principal Investigator (University of Liverpool) for the Characterizing Post Ebola Syndrome, Sierra Leone which supports clinical care for Ebola Survivors and provides a research platform for collaborative research into Post Ebola Syndrome.
Prizes or Honours
- Clinical Lecturer Prize (University of Liverpool, 2017)
- Ebola Medal (UK Government, 2016)
- Prize Scholarship for HIV Vaccine Research (Bill and Melinda Gates Foundation, 2007)
- Medical Elective Prize (Wellcome Trust, 2006)
- Prize in Psychiatry (University of Oxford, 2005)
- Graham Kerr Prize in Parasitology (University of Glasgow, 1993)